Maria Jose
Maria Jose Bermejo Oses, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100035781 | Composition which Contains a Mixture of Mono-, Di and Triglycerides and Glycerine - The present invention relates to a composition which contains a mixture of alkoxylated mono-, di-, and triglycerides and glycerine of formula wherein R′ represents H or CH3, and each one of m, n, or l represents, independently, a number from 0 to 20, the sum of m, n, and l being in the range of 1.5 to 20, characterized in that in the acyl group represented by —CO—R, R represents an alkyl or alkenyl group, linear or branched, of 6 to 11 carbon atoms, and the proportion by weight (i)+(ii)+(iii)/(iv) is in the range of 2.0:0.5 to 0.5:3; and to a method for the preparation of said composition, the detergent compositions which contain said compositions, and the use of said composition as surfactant or co-surfactant in the detergent compositions, particularly in detergent compositions, especially, but not exclusively, suitable for washing fabrics, suitable for manual dishwashing, for washing the hair or for personal hygiene. | 02-11-2010 |
20100041576 | Detergent Composition - The present invention relates to an aqueous detergent composition comprising the following elements in the indicated amounts expressed as percentage by weight: a) 0.1-15% of at least one alkyl ether carboxylate of formula (I): R—O—(CH | 02-18-2010 |
20100331231 | NON-RINSE FABRIC SOFTENER - The invention relates to compositions which are suitable as fabric softeners, particularly for softening fabrics that have been washed with highly concentrated detergents. Said compositions are obtainable by esterification of a C | 12-30-2010 |
Maria Jose Camarasa, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130338096 | Compositions for the Treatment or Prophylaxis of Viral Infections - A compound of the general formula (III): wherein X is O, S, NH or CH | 12-19-2013 |
20150080318 | Compositions for the Treatment or Prophylaxis of Viral Infections - A compound of the general formula (III): wherein X is O, S, NH or CH | 03-19-2015 |
Maria Jose Campagnole Santos, Belo Horizonte-Mg BR
Patent application number | Description | Published |
---|---|---|
20080312129 | Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases - The present invention is characterized by the use of Mas G-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for study, prevention and treatment of diseases. It is further characterized by the use of Mas G-protein-coupled receptor agonist and antagonists for modulation of the apoptotic activity involving alterations in the activity of the protein kinase B/Akt. Another characteristic of the invention is the use of Mas G-protein-coupled receptor agonists and antagonists, including the Ang-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, as modulators of apoptotic activity for study, prevention and treatment of degenerative diseases of organs and systems, as an auxiliary measure for organs transplantation, treatment with embryonic, non-embryonic stem cells, re-implantation of organs and tissues and other treatments that need temporary or chronic reduction of the apoptotic activity, not limitative. The invention further claims the use of Mas G-protein-coupled receptor agonists and antagonists, including the Angiotensin-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, formulated with pharmaceutically and pharmacologically acceptable excipients or carriers, as modulators of the apoptotic activity. | 12-18-2008 |
Maria Jose Carreira Nouche, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20120195480 | METHOD, APPARATUS, AND SYSTEM FOR RETINAL IMAGE ANALYSIS - Disclosed embodiments include a method for retinal image analysis implemented in a medical system with one or more processors comprising the method steps of: (a) locating an optical disk on the retinal images and establishing a plurality of circumferences centered at the disk; (b) detecting a plurality of vessels within a region defined by said circumferences' radii using a crease-based algorithm; (c) extracting a plurality of vessel segments based on a deformable models (snakes) algorithm; (d) measuring a plurality of vessel calibers; (e) classifying each vessel as a vein and an artery; and (f) computing an arteriolar-to-venular ratio. | 08-02-2012 |
20120195481 | METHOD, APPARATUS, AND SYSTEM FOR AUTOMATIC RETINAL IMAGE ANALYSIS - Disclosed embodiments include a method for retinal image analysis implemented in a medical system with one or more processors comprising the method steps of: (a) locating an optical disk on the retinal images and establishing a plurality of circumferences centered at the disk; (b) detecting a plurality of vessels within a region defined by said circumferences' radii using a crease-based algorithm; (c) extracting a plurality of vessel segments based on a deformable models (snakes) algorithm; and d) automatically classifying the vessels and computing clinical parameters. | 08-02-2012 |
Maria Jose Chamorro Salillas, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130280302 | PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF - The invention relates to a pharmaceutical product comprising an allergen extract or an allergoid thereof for the treatment and/or prevention of allergy and allergic asthma caused by house dust mites, which extract comprises at least one extract of mite bodies selected from the following groups a)-b): a) An extract of Der p mite bodies, and b) An extract of Der f mite bodies, and at least one extract of mite cultures selected from the following groups c)-g): c) An extract of Der p faecal particles, d) An extract of Der f faecal particles, e) An extract of Der f whole mite culture, f) An extract of an Der p whole mite culture, and g) a combination of extracts c) to f). | 10-24-2013 |
Maria Jose Churruca, Campana AR
Patent application number | Description | Published |
---|---|---|
20100155250 | SYNTHESIS OF OIL CONTAINING MICROCAPSULES AND THEIR USE IN FUNCTIONAL COMPOSITE COATINGS - Systems and methods for the synthesis of lubricant-containing microcapsules are disclosed. Embodiments of composite nickel and copper coatings containing capsules with liquid lubricating oil cores are also disclosed. In certain embodiments, microcapsules can be incorporated into a metal plating solution to perform composite electrodeposition to obtain self lubricant metallic coatings. In some embodiments, much lower friction coefficient (˜0.8) and far better wear resistance was obtained with the copper/microcapsules composite. | 06-24-2010 |
Maria Jose Galotto, Santiago CL
Patent application number | Description | Published |
---|---|---|
20140154426 | Process for Obtaining a Film Comprised of the Incorporation of Naturally-Sourced Antimicrobial Agents in a Polymeric Structure to Develop Packages for Increasing the Shelf Life of Refrigerated Meat, Preferentially Refrigerated Fresh Salmon - A process for obtaining a film comprised of the incorporation of naturally-sourced antimicrobial agents in a polymeric structure to develop packages for increasing the shelf life of refrigerated meat, preferentially refrigerated fresh salmon, wherein said process comprises the following steps: a) obtaining microcapsules of a naturally-sourced antimicrobial agent in an enveloping medium, comprising the steps of: a1) producing an aqueous phase dissolving gum arabic (Quimatic) and Tween 20 in distilled water; a2) producing an oily phase through a solution of the naturally-sourced antimicrobial agent with a mixture of thymol and carvacrol; a3) preparing an emulsion incorporating the aqueous phase onto the oily phase; b) incorporating the microcapsules into polymers, previously treating them in order to reduce their surface tension (corona treatment), the microcapsules settling over the film, and letting them dry on a stove at controlled temperature. | 06-05-2014 |
Maria Jose Guerrero Martinez, Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20110268747 | STXBP1 AS PSYCHIATRIC BIOMARKER IN MURINE MODEL SYSTEM AND THEIR USES - A non-human transgenic animal having a polynucleotide encoding an STXBP1 polypeptide, which polynucleotide is operably linked to a promoter, wherein said transgenic animal has greater than wild-type expression of the STXBP1 polypeptide in at least one brain region, as well as related vectors, methods of producing transgenic animals, in vitro and in vivo screening methods for potential therapeutic agents, and methods for treating and diagnosing neuropsychiatric illness are disclosed. | 11-03-2011 |
Maria Jose Guillen Navarro, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110070232 | Combination Therapy with an Antitumor Alkaloid - The present invention relates to combinations of PM00104 with other anticancer drugs, and the use of these combinations in the treatment of cancer. | 03-24-2011 |
20130266666 | Combination Therapy with an Antitumor Alkaloid - The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer. | 10-10-2013 |
Maria Jose Martinez De Lizarduy Romo, Pamplona ES
Patent application number | Description | Published |
---|---|---|
20100280672 | System for regulating the active power of a wind farm - An active power regulation process and system of a wind farm comprising an array of aerogenerators (AI), a communications network (RS), and a monitoring and control system (ST). The system of the invention comprises: | 11-04-2010 |
Maria Jose Martinez Lorenzo, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20120189690 | Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein - The invention relates to the field of biotechnology and medicine. The invention specifically relates to a compound comprising a liposome covered or decorated at least with the extracellular domain of the APO2L/TRAIL protein, and to the use thereof far developing a medicament preferably for the treatment of a cancer or inflammatory or autoimmune diseases, such as rheumatoid arthritis. | 07-26-2012 |
Maria Jose Merino AzcÁrraga, Vizcaya ES
Maria Jose Montes Pita, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130128329 | DEVICE FOR CONCENTRATING SOLAR RADIATION WITH LONGITUDINAL MIRRORS AND A LONGITUDINAL RECEIVER - A device for concentrating solar radiation ( | 05-23-2013 |
20130152914 | PANEL WITH LONGITUDINAL MIRRORS FOR A SOLAR POWER PLANT - A receiver for a solar power plant with mirrors ( | 06-20-2013 |
Maria Jose NuÑez Garcia, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20160074317 | ANTIOXIDANT EXTRACT FROM BROWN MACROALGAE AND METHOD FOR OBTAINING SAME - The invention relates to a method for obtaining antioxidant extracts from macroalgae using ultrasound-assisted continuous aqueous extraction. The process can be performed using fresh alga or dry alga, after resuspending same in water. A suspension of alga in water is prepared with a solid concentration of between 10 and 30%. The mixture is fed to an ultrasonic disruption system. The extract is filtered and lyophilized, obtaining total polyphenol concentrations of 62.4 mg eq. of phloroglucinol/g of lyophilisate with | 03-17-2016 |
Maria Jose Pazos Guldris, Lugo ES
Patent application number | Description | Published |
---|---|---|
20110065138 | Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation - The present invention relates to a quantitative method for detecting yessotoxins in fishery products based on the activation the toxin produces on cellular phosphodiesterases and the therapeutic use of this activation. The cellular target of yessotoxin (YTX) and its analogs is the activation of phosphodiesterases (PDEs). The PDEs-YTX bond produces a measurable signal. The bond can be quantified by means of an affinity biosensor or by fluorescence. The biosensor detects biomolecular interactions and allows determining the presence of YTX due to its interaction with PDEs. The variations in the degradation rate of the fluorescent derivative anthraniloyl-cAMP are determined by means of plate fluorescence. The rate at which the PDEs degrade this molecule increases in the presence of YTX. YTX inhibits immunological activation of mastocytes in rats and induces a cytotoxic effect in human hepatocarcinoma cells, which implies two therapeutic uses of YTXs as an antiallergic and antitumor compound. | 03-17-2011 |
Maria Jose Perez Puerto, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090124686 | GSK-3 INHIBITORS - The invention relates to urea derivatives of formula (I) as inhibitors of glycogen synthase kinase 3β, GSK-3, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which GSK-3 is involved, such as Alzheimer's disease or non-insulin dependent diabetes mellitus. | 05-14-2009 |
20090192204 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I) for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 07-30-2009 |
20090221647 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I), for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 09-03-2009 |
Maria Jose Pretel Sanchez, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110118253 | 5-METHYL-1-(NAPHTHALEN-2-YL)-1H-PYRAZOLES USEFUL AS SIGMA RECEPTOR INHIBITORS - The invention relates to compounds having the formula (I): | 05-19-2011 |
Maria Jose Ribal Caparros, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100086932 | BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD - The present invention relates to an in vitro non-invasive bladder cancer diagnosis and/or prognosis method based on the detection and quantification in bladder fluids of the gene expression of certain genes and/or combinations thereof acting as genetic markers of said disease. A bladder cancer diagnosis and/or prognosis kit based on the use of a set of probes suitable for the detection and quantification of the expression pattern of said genes is also contemplated. | 04-08-2010 |
Maria Jose Silvino, Franca BR
Patent application number | Description | Published |
---|---|---|
20110166226 | PROCESS FOR OBTAINING AN EXTRACT RICH IN ROSMARINIC ACID (RA) FROM THE PLANT ORIGANUM VULGARE AND ITS USE FOR THE TREATMENT OF DIABETES - Diabetes consists of a worldwide public health concern that leads to high levels of morbidity and premature mortality and affects millions of people in countries of any level of development. It is estimated that there are more than 150 million people with diabetes in the world, wherein projections from the World Health Organization (WHO) for 2025 such amount may get to 300 million cases. | 07-07-2011 |
Maria Jose Tames Alonso, Donostia ES
Patent application number | Description | Published |
---|---|---|
20140166123 | LAMINAR AIR FLOW CABINET - A laminar air flow cabinet of the type comprising a laminar flow portion and two adjacent portions, a first adjacent portion located above the laminar portion and a second adjacent portion located below the laminar flow portion, in which the cabinet comprises at least one fan blowing air from the first of these adjacent portions to the laminar flow portion through a first filter, and a second filter located in the second of the adjacent portions, the cabinet comprising at least one spray located in the laminar flow portion, a hydraulic pump injecting fluid through the spray and at least one impermeable surface located between the second filter and the laminar flow portion. | 06-19-2014 |
Maria Jose Travassos Leandro, Monte Da Caparica PT
Patent application number | Description | Published |
---|---|---|
20090053784 | EXPRESSION OF AN ACTIVE CARRIER FROM XYLOSE IN GENETICALLY MODIFIED SACCHAROMYCES CEREVISAE - The present invention confers to the ferementative yeast | 02-26-2009 |
Maria José Bermejo Oses, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100041576 | Detergent Composition - The present invention relates to an aqueous detergent composition comprising the following elements in the indicated amounts expressed as percentage by weight: a) 0.1-15% of at least one alkyl ether carboxylate of formula (I): R—O—(CH | 02-18-2010 |
Maria José Chamorro Salillas, Madrid ES
Patent application number | Description | Published |
---|---|---|
20120076825 | PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF - The invention relates to a pharmaceutical product comprising an allergen extract or an allergoid thereof for the treatment and/or prevention of allergy and allergic asthma caused by house dust mites, which extract comprises at least one extract of mite bodies selected from the following groups a)-b): a) An extract of Der p mite bodies, and b) An extract of Der f mite bodies, and at least one extract of mite cultures selected from the following groups c)-g): c) An extract of Der p faecal particles, d) An extract of Der f faecal particles, e) An extract of Der f whole mite culture, f) An extract of an Der p whole mite culture, and g) a combination of extracts c) to f). | 03-29-2012 |
Maria José Cofre Gaete, San Pedro De La Paz CL
Patent application number | Description | Published |
---|---|---|
20100233652 | Buccal Device for Isolating the Operating Field - The invention relates to dental devices for isolating a working area, comprising a substantially concave main piece having two upper ends and a substantially round edge on a lower area of the main piece, the round edge being adaptable to a patient's mouth; a substantially concave lower cover attached to the lower area of the main piece; two removable pieces each attached to each of the two upper ends of the main piece; and two upper covers each attached to each of the two removable pieces, the upper covers each having a protuberance to allow attachment of a rubber dam. Also provided are methods for providing isolation of a working area in a patient's mouth. | 09-16-2010 |
Maria José Cofre Gaete, San Pedro De La Paz CL
Patent application number | Description | Published |
---|---|---|
20100233652 | Buccal Device for Isolating the Operating Field - The invention relates to dental devices for isolating a working area, comprising a substantially concave main piece having two upper ends and a substantially round edge on a lower area of the main piece, the round edge being adaptable to a patient's mouth; a substantially concave lower cover attached to the lower area of the main piece; two removable pieces each attached to each of the two upper ends of the main piece; and two upper covers each attached to each of the two removable pieces, the upper covers each having a protuberance to allow attachment of a rubber dam. Also provided are methods for providing isolation of a working area in a patient's mouth. | 09-16-2010 |
Maria José Dus Santos, Buenos Aires AR
Patent application number | Description | Published |
---|---|---|
20110061136 | FUSION PROTEIN THAT DIRECTS VACCINE ANTIGENS TO ANTIGEN-PRESENTING CELLS, AND APPLICATIONS THEREOF - Fusion protein with directioning of vaccinal antigens toward antigen-presenting cells and the applications thereof. This invention relates to a gene construct that comprises, operatively bound, at least one nucleotide sequence (A) that encodes a polypeptide with SEQ ID NO: 1, which has a region that recognises the β chain of the class-II DR antigen present on the surface of antigen-presenting cells; and one nucleotide sequence (B) that encodes a vaccinal antigen of interest. Moreover, this invention relates to recombinant vectors useful for the expression of the gene construct of the invention, transgenic cells and plants transformed or transfected with said vectors, fusion proteins encoded by the gene construct of the invention and vaccines that comprise said fusion proteins. | 03-10-2011 |
Maria José Dus Santos, Buenos Aires AR
Patent application number | Description | Published |
---|---|---|
20110061136 | FUSION PROTEIN THAT DIRECTS VACCINE ANTIGENS TO ANTIGEN-PRESENTING CELLS, AND APPLICATIONS THEREOF - Fusion protein with directioning of vaccinal antigens toward antigen-presenting cells and the applications thereof. This invention relates to a gene construct that comprises, operatively bound, at least one nucleotide sequence (A) that encodes a polypeptide with SEQ ID NO: 1, which has a region that recognises the β chain of the class-II DR antigen present on the surface of antigen-presenting cells; and one nucleotide sequence (B) that encodes a vaccinal antigen of interest. Moreover, this invention relates to recombinant vectors useful for the expression of the gene construct of the invention, transgenic cells and plants transformed or transfected with said vectors, fusion proteins encoded by the gene construct of the invention and vaccines that comprise said fusion proteins. | 03-10-2011 |
Maria José Gómara Elena, Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20100197606 | NON-PROTEOLYSABLE OLIGOPEPTIDES THAT INHIBIT GLYCOPROTEIN GP41 OF THE AIDS VIRUS - The invention relates to non-proteolysable oligopeptides that inhibit glycoprotein 41 of the AIDS virus. More specifically, the invention relates to the identification of oligopeptides, particularly hexapeptides, (D), (L) or mixed, preferably D-hexapeptides, which inhibit the binding of a retrovirus to a target cell, thereby providing novel therapies against infection from the human immunodeficiency virus (HIV). The invention also relates to the use of said D-hexapeptides in the form of single components or complex mixtures as prophylactic or therapeutic agents for retroviral infections, especially human immunodeficiency virus type 1 (HIV-1). | 08-05-2010 |
Maria José Gómara Elena, Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20100197606 | NON-PROTEOLYSABLE OLIGOPEPTIDES THAT INHIBIT GLYCOPROTEIN GP41 OF THE AIDS VIRUS - The invention relates to non-proteolysable oligopeptides that inhibit glycoprotein 41 of the AIDS virus. More specifically, the invention relates to the identification of oligopeptides, particularly hexapeptides, (D), (L) or mixed, preferably D-hexapeptides, which inhibit the binding of a retrovirus to a target cell, thereby providing novel therapies against infection from the human immunodeficiency virus (HIV). The invention also relates to the use of said D-hexapeptides in the form of single components or complex mixtures as prophylactic or therapeutic agents for retroviral infections, especially human immunodeficiency virus type 1 (HIV-1). | 08-05-2010 |
Maria José LourenÇo Ferreira, Benedita PT
Patent application number | Description | Published |
---|---|---|
20150150357 | BACKPACK/BAG/HANDBAG WITH A CHAIR/BACKREST - A backpack/bag/handbag and a chair with backrest combination combines, two essential objects used in the outdoor activities: the personal transportation bag and the portable chair all-in-one. While addressing the technical problem of storage goods and seating which normally characterizes the outdoor activities such as going to the beach or public gardens. The invention object presents the characteristics of a bag/backpack, but, the back of the storage compartment of the bag/backpack articulates a seat with two planes: the back part of the backpack storage area and the back of the chair and the cushion seat. When the two planes and and the cushion seat are folded in the vertical position, the invention object can be used as a bag/backpack. To be used as a chair/backrest, the cushion seat is rotated to a horizontal angle and the two planes and move to an oblique angle transforming the invention into a chair. | 06-04-2015 |
Maria José Negro Álvarez, Madrid SE
Patent application number | Description | Published |
---|---|---|
20100151550 | METHOD FOR RECOVERING ENERGY FROM THE ORGANIC FRACTION OF SOLID URBAN WASTE AND ASSOCIATED FACILITY - The invention relates to a method for recovering energy from the organic fraction of urban solid waste comprising the following steps: a) the organic fraction is pre treated with mineral acids, preferably sulfuric acid, during which the fraction is heated by an outer thermal jacket with no steam injection or steam explosion, thereby producing a first slurry containing an insoluble solid susceptible to enzymatic attack by cellulases; b) a step comprising enzymatic hydrolysis using cellulases and simultaneous fermentation, using an ethanologenic microorganism, of the first slurry in order to obtain a second slurry containing diluted ethanol; and c) distillation of the second slurry such as to obtain wet ethanol, a recyclable liquid effluent and a solid. | 06-17-2010 |
Maria José Negro Álvarez, Madrid SE
Patent application number | Description | Published |
---|---|---|
20100151550 | METHOD FOR RECOVERING ENERGY FROM THE ORGANIC FRACTION OF SOLID URBAN WASTE AND ASSOCIATED FACILITY - The invention relates to a method for recovering energy from the organic fraction of urban solid waste comprising the following steps: a) the organic fraction is pre treated with mineral acids, preferably sulfuric acid, during which the fraction is heated by an outer thermal jacket with no steam injection or steam explosion, thereby producing a first slurry containing an insoluble solid susceptible to enzymatic attack by cellulases; b) a step comprising enzymatic hydrolysis using cellulases and simultaneous fermentation, using an ethanologenic microorganism, of the first slurry in order to obtain a second slurry containing diluted ethanol; and c) distillation of the second slurry such as to obtain wet ethanol, a recyclable liquid effluent and a solid. | 06-17-2010 |
Maria José Puertollano Abascal, Las Arenas-Guecho (vizcaya) ES
Patent application number | Description | Published |
---|---|---|
20130266476 | ANTI-VEINING ADDITIVE FOR THE PRODUCTION OF CASTING MOLDS AND CORES - The present invention belongs to the field of the additives for molding sands used in the manufacture of casting molds and cores. More specifically, the present invention relates to an additive to prevent veining in the manufacture of metal parts, to a molding sand comprising said additive, to a core or mold prepared from said molding sand and to a metal part prepared by means of using one of said cores or molds. | 10-10-2013 |
Maria José Puertollano Abascal, Las Arenas-Guecho (vizcaya) ES
Patent application number | Description | Published |
---|---|---|
20130266476 | ANTI-VEINING ADDITIVE FOR THE PRODUCTION OF CASTING MOLDS AND CORES - The present invention belongs to the field of the additives for molding sands used in the manufacture of casting molds and cores. More specifically, the present invention relates to an additive to prevent veining in the manufacture of metal parts, to a molding sand comprising said additive, to a core or mold prepared from said molding sand and to a metal part prepared by means of using one of said cores or molds. | 10-10-2013 |
Maria José Rueda Lopez, Las Palmas ES
Patent application number | Description | Published |
---|---|---|
20090318040 | BUOYAGE AND ENVIRONMENTAL MONITORING INSTRUMENT FOR USE ON REGATTA COURSES, COMPRISING AN INFLATABLE PNEUMATIC PLATFORM AND A MODULAR MAST WHICH CAN BE FOLDED AND TRANSPORTED IN A REDUCED-SIZE COMPACT PACKING CONTAINER - The present invention relates to an instrument for marking and environmental monitoring in regatta courses. Incorporated by inflatable pneumatic platform and modular mast, foldable and transportable in compact packing of reduced size. It is intended to simultaneously define the area of conducting such nautical trials, at the same time as the environmental conditions thereof are characterized, in both meteorological and oceanographic terms. The system comprises an inflatable pneumatic float ( | 12-24-2009 |
Maria José Rueda Lopez, Las Palmas ES
Patent application number | Description | Published |
---|---|---|
20090318040 | BUOYAGE AND ENVIRONMENTAL MONITORING INSTRUMENT FOR USE ON REGATTA COURSES, COMPRISING AN INFLATABLE PNEUMATIC PLATFORM AND A MODULAR MAST WHICH CAN BE FOLDED AND TRANSPORTED IN A REDUCED-SIZE COMPACT PACKING CONTAINER - The present invention relates to an instrument for marking and environmental monitoring in regatta courses. Incorporated by inflatable pneumatic platform and modular mast, foldable and transportable in compact packing of reduced size. It is intended to simultaneously define the area of conducting such nautical trials, at the same time as the environmental conditions thereof are characterized, in both meteorological and oceanographic terms. The system comprises an inflatable pneumatic float ( | 12-24-2009 |
María José Alejandre Pérez, Granada ES
Patent application number | Description | Published |
---|---|---|
20160139129 | BIOMARKERS FOR THE DIAGNOSIS AND THE RESPONSE TO TREATMENT OF PANCREATIC CANCER - The invention related to biomarkers, a method and a kit for early diagnosis of pancreatic cancer, in particular of pancreatic ductal adenocarcinoma (PDAC); and to biomarkers, a method and a kit or device for predicting or prognosticating an individual's response to combination treatment with a nucleoside analogue (preferably gemcitabine) and with a growth factor receptor (preferably erlotinib) in patients with pancreatic ductal adenocarcinoma. | 05-19-2016 |
María José Alfonso Alegre, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20130217852 | BIODEGRADABLE POLYESTERETHERAMIDE - A biodegradable polyesteretheramide for manufacturing films and moulded products, for example for application in the protection of foodstuff products and films for agriculture, contains a compound with at least 3 groups capable of reacting with one or several types of the active groups present in the reaction mixture, that is, compounds which, while containing ether groups in their structure, have active groups capable of reacting in the reaction mixture to form amide groups, and which simplifies and shortens the preparation process, reducing its economic cost and obtaining products of greater transparency and higher strain at failure, while maintaining other properties such as resistance to tearing and puncture, and allowing greater widths of films to be made with smaller thicknesses. | 08-22-2013 |
20140296389 | Bio-Based and Biodegradable Polymer - Bio-based and biodegradable polymer of the type used in the manufacture of films and injected or moulded products, for example, for applications of containers, bags, healthcare products and films for agriculture or other applications in which the biodegrading characteristic is of interest, has a biodegradable polymer, thermoplastic starch in the co-continuous or continuous phase and at least one polymer that comes from a stable dispersion of the polymer in water or latex. This increases the thermoplastic starch content and thus decreases the biodegradable polymer and obtains films of a greater width by blow extrusion, with similar tensile properties. This provides the added advantage of a lower cost in raw materials, less impact on the environment and greater production. | 10-02-2014 |
María José Alonso Fernández, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20140023703 | NANOCAPSULES WITH A POLYMER SHELL - The invention relates to a system for administering active ingredients, including nanocapsules comprising an oil, a cationic surfactant and a polymer selected from the group consisting of polyglutamic acid (PGA), polyglutamic-polyethyleneglycol acid (PGA-PEG), hyaluronic acid (HA) and polyasparagine (PAsn) or a combination of same and, optionally, an active ingredient, with the condition that when the polymer includes polyglutamic acid or polyglutamic-polyethyleneglycol acid (PGA-PEG) the active ingredient is not a didemnin or a tamandarin. The invention also relates to methods for obtaining said nanocapsule system, the pharmaceutical compositions thereof and the use of same in medicine. | 01-23-2014 |
20160038433 | NANOCAPSULES OF PROTAMINE - The present invention relates to the design and development of nanocapsule systems for the administration of active substances, wherein the nanocapsules of the system have a mean diameter less than 1 μm and are characterized by comprising (a) a protamine shell, (b) an oily core, and one or more surfactants characterized by having a hydrophilic-lipophilic ratio greater than 8, provided that said surfactant is not a phospholipid. | 02-11-2016 |
María José Bermejo Osés, Barberà Del Vallès-Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090269294 | Fragrance Precursor - The invention relates to a compound of the following formula (I) X—CR | 10-29-2009 |
María José Bermejo Osés, Barberà Del Vallès-Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090269294 | Fragrance Precursor - The invention relates to a compound of the following formula (I) X—CR | 10-29-2009 |
María José Bermejo Osés, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100035781 | Composition which Contains a Mixture of Mono-, Di and Triglycerides and Glycerine - The present invention relates to a composition which contains a mixture of alkoxylated mono-, di-, and triglycerides and glycerine of formula wherein R′ represents H or CH3, and each one of m, n, or l represents, independently, a number from 0 to 20, the sum of m, n, and l being in the range of 1.5 to 20, characterized in that in the acyl group represented by —CO—R, R represents an alkyl or alkenyl group, linear or branched, of 6 to 11 carbon atoms, and the proportion by weight (i)+(ii)+(iii)/(iv) is in the range of 2.0:0.5 to 0.5:3; and to a method for the preparation of said composition, the detergent compositions which contain said compositions, and the use of said composition as surfactant or co-surfactant in the detergent compositions, particularly in detergent compositions, especially, but not exclusively, suitable for washing fabrics, suitable for manual dishwashing, for washing the hair or for personal hygiene. | 02-11-2010 |
María José Castello Llopis, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100242133 | MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE - The invention relates to the use of a mutation for the generation of virus-resistant mutant plants and, specifically, to the use of mutation 8.1 of the AtDBP1 gene of | 09-23-2010 |
María José Castello Llopis, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100242133 | MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE - The invention relates to the use of a mutation for the generation of virus-resistant mutant plants and, specifically, to the use of mutation 8.1 of the AtDBP1 gene of | 09-23-2010 |
María José DÍaz CabaÑas, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100025299 | Catalyst based on solid microporous crystalline material and method of improving diesel fraction quality using said catalyst - The invention relates to a catalyst consisting of at least: one matrix comprising at least one oxide which is selected from an amorphous oxide, an oxide with low crystallinity and a mixture of both; at least one solid microporous crystalline material which, in the calcined and anhydrous state, has the molar compositions X | 02-04-2010 |
María José DÍaz CabaÑas, Valencia ES
Patent application number | Description | Published |
---|---|---|
20080267860 | Crystalline Microporous Material Of Zeolitic Nature - A crystalline microporous material of zeolitic nature (ITQ-41) having in its calcined form a chemical composition represented by the empirical formula: | 10-30-2008 |
20090124484 | Microporous Crystalline Material, Zeolite ITQ-33, Method of Preparation and Use - The invention relates to a microporous crystalline material which is characterised in that it has the following chemical composition in the calcined state: X | 05-14-2009 |
20090220661 | MICROPOROUS CRYSTALLINE MATERIAL, ZEOLITE ITQ-37, PREPARATION METHOD AND USE - The present invention relates to a microporous crystalline material characterized in that it has the following chemical composition in the calcined from: | 09-03-2009 |
20100025299 | Catalyst based on solid microporous crystalline material and method of improving diesel fraction quality using said catalyst - The invention relates to a catalyst consisting of at least: one matrix comprising at least one oxide which is selected from an amorphous oxide, an oxide with low crystallinity and a mixture of both; at least one solid microporous crystalline material which, in the calcined and anhydrous state, has the molar compositions X | 02-04-2010 |
María José Gil Morrio, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100115668 | Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with disease caused by necrotrophic fungal pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the OCP3 gene of | 05-06-2010 |
María José Gil Morrio, Valencia ES
Patent application number | Description | Published |
---|---|---|
20090106858 | Isolation and Characterization of the Csb3-1 Mutant of Arabidopsis Thaliana and Use Thereof as a Regulator of Resistance in Plants to Diseases Caused by Biotrophic Pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the identification and characterization of the csb3-1 mutant of | 04-23-2009 |
20100115668 | Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with disease caused by necrotrophic fungal pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the OCP3 gene of | 05-06-2010 |
María José Guillén Navarro, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130266666 | Combination Therapy with an Antitumor Alkaloid - The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer. | 10-10-2013 |
María José Montes Pita, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130152914 | PANEL WITH LONGITUDINAL MIRRORS FOR A SOLAR POWER PLANT - A receiver for a solar power plant with mirrors ( | 06-20-2013 |
María José Munoz Alonso, Madrid ES
Patent application number | Description | Published |
---|---|---|
20160129128 | ANTIBODY DRUG CONJUGATES - Drug conjugates of formula [D-(X)b-(AA)w-(L)-]n-Ab wherein: D is a drug moiety having the following formula (I) or a pharmaceutically acceptable salt, ester, solvate, tautomer or stereoisomer thereof, wherein: A is selected from (II) and (III) R | 05-12-2016 |
María José Pajares Villandiego, Pamplona ES
Patent application number | Description | Published |
---|---|---|
20150072361 | Lung Cancer Molecular Markers - The invention provides a method of diagnosis and/or prognosis of lung cancer, the method comprising the steps of: (a) determining the level of a C4 activation fragment in a test sample, and (b) comparing the level of the test sample with the level of a C4 activation fragment detected in a control sample, wherein if the level of C4 activation fragment is higher than the level in a reference control, it is indicative that the subject suffers lung cancer or has a bad prognosis. | 03-12-2015 |
María José Sanchez Gallardo, Alicante ES
Patent application number | Description | Published |
---|---|---|
20110170949 | REMOVABLE PNEUMATIC MARKER WITH UNDERGROUND ANCHORING - A description is given of a bollard designed specifically for signalling in places through which, road traffic passes, both in cities, towns and villages and on roads and motorways. The bollard comprises two separate elements, of which one provides lower anchorage to the ground, and is stiff, and the other is the section of the bollard itself, and is elastic, flexible and capable of being fitted to the lower element by means of a bayonet configuration. In the rapid recovery version, the upper flexible element incorporates an inflatable pneumatic ball inside. The whole bollard has a lid that can be fitted to the lower anchoring element when the upper one has been removed, this lid being shaped to remain flush, coupled, to the surface of the ground. | 07-14-2011 |
María José Tamés Alonso, Donostia (gipuzkoa) ES
Patent application number | Description | Published |
---|---|---|
20120318402 | Machine and Method for the Automatic Preparation of Intravenous Medication - A machine for the automatic preparation of an intravenous medication is provided. In one implementation the machine has a chamber with a starting products area where at least one receptacle is disposed with a base product from which the intravenous medication is generated, a transfer tools area where at least one transfer tool that is used to prepare the required medication is disposed, a prepared products area where at least one container to house the prepared medication is disposed, and a first robot to handle the transfer tool, the first robot being adapted to transport the transfer tool between the transfer tools area, the starting products area and the prepared products area in order to prepare the intravenous medication. | 12-20-2012 |
20140150379 | MACHINE AND METHOD FOR THE AUTOMATIC PREPARATION OF INTRAVENOUS MEDICATION - Machine and method for the automatic preparation of medication, comprising:—a starting products area comprising at least one receptacle with bane products; a transfer tools area further comprising at least one transfer tool; a prepared products area comprising at least one container; and one robot with holding means for transporting the receptacle, the transfer tool and/or the container; wherein the robot, the starting products area, the transfer tools area, and the prepared products area are disposed in the same cabinet or chamber of the machine, so that the robot is adapted to transport mo receptacle, the transfer tool and/or the container between the areas in the chamber. The machine further comprising a holding device between the receptacle, the transfer tool or the container and the robot's holding means, said holding device comprising elastic means for fixation to different sizes/forms of receptacles, transfer tools or containers. | 06-05-2014 |
20140202588 | Machine and Method For The Automatic Preparation Of Intravenous Medication - A machine for the automatic preparation of an intravenous medication is provided. In one implementation the machine has a chamber with a starting products area where at least one receptacle is disposed with a base product from which the intravenous medication is generated, a transfer tools area where at least one transfer tool that is used to prepare the required medication is disposed, a prepared products area where at least one container to house the prepared medication is disposed, and a first robot to handle the transfer tool, the first robot being adapted to transport the transfer tool between the transfer tools area, the starting products area and the prepared products area in order to prepare the intravenous medication. | 07-24-2014 |
María José Tamés Alonso, Donostia (gipuzkoa) ES
Patent application number | Description | Published |
---|---|---|
20120318402 | Machine and Method for the Automatic Preparation of Intravenous Medication - A machine for the automatic preparation of an intravenous medication is provided. In one implementation the machine has a chamber with a starting products area where at least one receptacle is disposed with a base product from which the intravenous medication is generated, a transfer tools area where at least one transfer tool that is used to prepare the required medication is disposed, a prepared products area where at least one container to house the prepared medication is disposed, and a first robot to handle the transfer tool, the first robot being adapted to transport the transfer tool between the transfer tools area, the starting products area and the prepared products area in order to prepare the intravenous medication. | 12-20-2012 |